As a global business development leader at XOMA, Ms. Donahue
increased value through fully- funded antibody discovery and development collaborations which delivered over $ 56M in realized revenue and had the potential for $500M in additional milestone and royalty payments.
As a member of the global business development teams within multi-national pharmaceutical companies, she
led global scouting for products or technologies, created and implemented standard procedures for approval and execution of deals, facilitated M&A asset evaluation, managed US, Europe and Asia collaborations to exceed pipeline and revenue expectations, and managed cross-functional, cross-national teams to bring two products through clinical development to launch.
Ms. Donahue holds a B.A. in biology and chemistry from Gustavus Adolphus College and a MBA in management from the University of St. Thomas.
Patricia Donahue, MBA